Processing Your Payment

Please do not leave this page until complete. This can take a few moments.

January 22, 2021

Private equity firms buy growing compounding pharmacy with Windsor plant

Photo | Sentry Commercial SCA Pharmaceuticals LLC now occupies 148,585 square feet in Windsor.

Two private equity firms bought SCA Pharmaceuticals, a compounding pharmacy with major operations in Windsor, the company announced Friday.

The Vistria Group and Excellere Partners acquired all of the issued and outstanding equity of SCA. The terms of the transaction were not disclosed.

Excellere, based in Denver, controls $1.36 billion of committed capital across three funds. Chicago-based Vistria focuses on investing in middle-market companies in health care, education and financial services.

“Both partners recognize the unprecedented growth that we have achieved and are committed to fast-tracking our expansion and automation goals.” SCA CEO Milton Boyer said.

No changes are planned for SCA’s daily operations after the purchase, according to a company statement.

Based in Arkansas, SCA runs sterile pharmaceutical manufacturing sites in Windsor and Little Rock. SCA provides compounded drugs to over 1,200 U.S. hospitals and health systems, making drugs that are otherwise not commercially available.

SCA expanded its Windsor manufacturing site on Rainbow Road by nearly 60,000 square feet in August as part of a company-wide expansion that increased its physical footprint by more than 50 percent.

The company opened the Windsor facility in fall 2017 and occupied a total of 148,585 square feet after the expansion, according to broker Sentry Commercial.

Sign up for Enews


Order a PDF